Originally published In Press as doi:10.1074/jbc.C000625200 on September 18, 2000
J. Biol. Chem., Vol. 275, Issue 48, 37752-37756, December 1, 2000
Molecular Basis for the p Phenotype
IDENTIFICATION OF DISTINCT AND MULTIPLE MUTATIONS IN THE
1,4-GALACTOSYLTRANSFERASE GENE IN SWEDISH AND JAPANESE
INDIVIDUALS*
Keiko
Furukawa
,
Koichi
Iwamura
,
Makoto
Uchikawa§,
Birgitta Nilsson
Sojka¶,
Joelle
Wiels
,
Tetsuya
Okajima
,
Takeshi
Urano
, and
Koichi
Furukawa
**
From the
Department of Biochemistry II, Nagoya
University School of Medicine, Tsurumai, Nagoya 466-0065, Japan,
§ Central Blood Center, Japanese Red Cross, Hiroo 4-1-31, Shibuya-Ku, Tokyo 150-0012, Japan, ¶ Department of
Transfusion Medicine, Umeå University Hospital, S-901 85 Umeå,
Sweden, and
CNRS UMR 1598, Institut Gustave Roussy, Villejuif
Cedex, 94805 France
Received for publication, September 7, 2000
 |
ABSTRACT |
p phenotype individuals lack both
Pk (Gb3) and P (Gb4) glycolipid antigens of
the P blood group system. To explore the molecular basis for this
phenotype, DNA sequences of Gb3 synthase (
1,4-galactosyltransferase;
1,4Gal-T) in six p phenotype individuals from Japan and Sweden were
analyzed. A missense mutation P251L and a nonsense mutation W261stop in
three and one Japanese indivuiduals, respectively, and missense
mutations M183K and G187D in one each of two Swedish p individuals were
found, indicating that p individuals from Japan and Sweden have
distinct and multiple homozygous point mutations in the coding region.
In the function analysis of the mutated
1,4Gal-Ts by the
transfection of the expression vectors, P251L and M183K mutations
showed complete loss of enzyme function, and W261stop and G187D
mutations resulted in the marginal activity. BLAST analysis of
homologous sequences of
1,4Gal-T revealed that three residues,
Met183, Gly187, and Pro251,
at which missense mutations were found, were highly conserved among all
species examined, suggesting their importance for the function of
1,4Gal-T.
 |
INTRODUCTION |
The P blood group system (1) has two common phenotypes,
i.e. P1 and P2 (with P) and three
rare phenotypes (p, P1k, and
P2k). p individuals are very rare, and the
defective structure was determined to be a glycolipid
globotriaosylceramide (Gb31),
consisting of Gal
1,4Gal
1,4Glc-ceramide (2, 3). Gb3 is converted
to P (globoside; Gb4), a major species of neutral glycolipids in human
erythrocytes. Therefore, erythrocytes deficient in the synthesis of Gb3
lack both Gb3 and Gb4 (3), whereas erythrocytes lacking Gb4 synthase
show absence of Gb4 (4) and accumulation of Gb3 (Pk
phenotype). P1 antigen, in contrast, belongs to the neolacto-series glycolipids and has been identified as
1,4Gal-neolactotetraosylceramide (5). Individuals of the p phenotype
lack P1 antigen, in addition to Gb3 and P (Gb4), presumably as a
result of deficiency in the enzyme
1,4-galactosyltransferase
(
1,4Gal-T) responsible for the synthesis of Gb3 from
lactosylceramide (3, 4) and also for reasons that are not fully understood.
Gb3 was detected not only in erythrocytes but in various epithelial
cells and hematopoietic cells including immature B cells in the
germinal center. Although Gb3 was defined as Burkitt
lymphoma-associated antigen (6), it is now called Gb3/CD77 and is
considered to be a differentiation antigen of B cell lineage (7, 8).
Gb3/CD77 is also known as a receptor molecule for Shiga-like toxins
from Escherichia coli O157, causing
hemolytic uremic syndrome (9). The presence/absence of Gb3/CD77 may,
therefore, have critical implications in long-term survival of mankind.
Recently, we have isolated cDNAs for
1,4Gal-T (9) and showed
that the introduction of this cDNA could reconstitute the functional receptor for verotoxins leading to apoptosis (10). In the
present study, we have analyzed the molecular basis of Pk/p
antigen phenotypes by the investigation of abnormalities in the
1,4Gal-T gene in p phenotype individuals from
Japan and Sweden. Although Steffensen et al. (11) reported
that Swedish p individuals have a missense mutation at M183K, we show
that Japanese p individuals have different and multiple missense or
nonsense point mutations in the coding region. We also defined another
missense mutation in a Swedish p individual. These mutations seem to
have been generated after the divergence of the two ethnic groups. The
importance of the defined mutation sites in the enzyme function is
discussed based on the aligned genes from the BLAST data base.
 |
EXPERIMENTAL PROCEDURES |
Sequence Analysis of the
1,4Gal-T Gene--
The
1,4Gal-T gene was amplified by polymerase chain reaction
(PCR) using PfuTurboTM DNA polymerase (Stratagene) from
genomic DNAs extracted from peripheral mononuclear cells. The four sets
of primers used are as follows: 1) 5'primer,
5'-TGGCGGGTGCTCATCTCTTG-3' (in the first intron) and 3'primer,
5'-TTGGTCCGG TCTGAAGTCTC-3'; 2) 5'primer, 5'-CCACTCCAGGCAACATCTTC-3'
and 3'primer, 5'-AGGTAGATGCCGCCGAACTT-3'; 3) 5'primer,
5'-GACGCCTCCAGGATCGCACT-3' and 3'primer, 5'-CTCCTCCGGGTTGATGTCCT-3'; and 4) 5'primer, 5'-GCAGGACTGGAAGAA GTAC-3' and 3'primer, 5'-GCCCC ATCAGGAGCAGGTTG-3'. Conditions of PCR consisted of denaturing at
94 °C for 1 min, annealing at 55 °C for 1 min, and then extension at 74 °C for 1 min. The amplified products were directly sequenced by dideoxy termination method using an ABI PRISM® 310 genetic analyzer (PE Biosystems).
Construction of Expression Vectors--
The
1,4Gal-T
expression vectors for individual mutants were constructed by PCR of
the coding region using a 5'primer containing an EcoRI site,
5'-ACCATGTCCAAGCCCCCCGACCTC-3', and a 3'primer containing an
XhoI site, 5'-CCCCTCACAAGTACATTTTCATG-3', and by subcloning
into EcoRI and XhoI sites of pcDNA3.1 (+)
vector (Invitrogen). Myc-tagged expression vectors were also
constructed with PCR products of the coding region to form a fusion
enzyme with the myc epitope at the N' terminus by subcloning into
BamHI and XhoI sites of myc-tagged pcDNA3
vector. The primers for the construction of the myc fusion protein were
as follows: 5'primer containing a BamHI site,
5'-TCCAAGCCCCCCGACCTC and 3'primer containing an XhoI site,
5'-CCCCTCACAAGTA CATTTTCATG-3'. These constructs were served to
sequence analysis to confirm the correct junctions and the absence of
artificial mutations.
Cell Culture--
A mouse fibroblast L cell line was kindly
provided by Dr. A. P. Albino (Sloan-Kettring Cancer Center, New
York, NY) and cultured in Dulbecco's modified Eagle's minimum
essential medium containing 7.5% fetal bovine serum.
Transfection--
Constructs for the gene expression were
introduced into cells by DEAE-dextran method as described previously
(10). After culture for 48 h, cells were harvested to be used for
further analyses.
Flow Cytometry--
Expression of Gb3/CD77 antigen was analyzed
by flow cytometry (Becton Dickinson) as described (10).
Enzyme Assay--
1,4Gal-T activity was measured as described
previously (10). Briefly, membrane fractions were prepared with a
nitrogen cavitation apparatus and centrifugation of the extracts
at 105,000 × g for 1 h. The enzyme products were separated
by Sep-Pak C18 (Waters) and then applied to a thin layer
chromatograph. Autofluorography was performed using a
BioImaging Analyzer BAS2000 (Fuji Film, Tokyo, Japan).
Western Immunoblotting--
The transfectant cells with
myc-tagged expression vectors were served for Western
immunoblotting after lysis with lysis buffer consisting of 20 mM Tris-HCl (pH7.4), 1.0% Nonidet P-40, 150 mM NaCl, 5 µg/ml aprotinin, and 1 mM phenylmethylsulfonyl
fluoride. Lysates containing 50 µg each of protein were separated by
SDS polyacrylamide gel electrophoresis and then blotted onto a
polyvinylidene difluoride membrane. The membranes were incubated with
anti-myc monoclonal antibody, and antibody binding was detected with an Vectastain ABC kit (Vector Laboratories, Inc.) according
to the manufacturer's instruction.
Intracellular Localization--
Myc-tagged expression vectors
were transfected into L cells and then stained by anti-myc monoclonal
antibody and fluorescein isothiocyanate-anti-mouse IgG after fixation.
The staining pattern was observed by confocal microscopy
(MicroRadiance; Bio-Rad).
 |
RESULTS |
Mutations in the
1,4Gal-T Gene in p
Individuals--
1,4Gal-T is the enzyme that synthesizes Gb3/CD77
(Pk antigen) from lactosylceramide (Fig.
1A). BLAST analysis of the
genomic structure of
1,4Gal-T revealed that the
1,4Gal-T gene consisted of at least 2 exons, and the
entire coding region existed in exon 2 (Fig. 1B). Using
primers designed as indicated in Fig. 1B, the entire coding
region of
1,4Gal-T was amplified with the genomic DNA as
a template and was directly sequenced. Sequence analyses of six p
samples consisting of four Japanese (J1, J2, J3, and J4) and two
Swedish (S1 and S2) individuals were performed. Four kinds of missense
mutation nucleotides (nt.), nt.109A
G (M37V), nt.548T
A (M183K),
nt.560G
A (G187D), and nt.752C
T (P251L), and one nonsense mutation
nt.783G
A (W261stop) were detected. Three of four Japanese
individuals contained the P251L mutation, and one of them contained
W261stop. Both of them were different from the mutations M183K and
G187D found in two Swedish donors (Fig. 1C). Two silent
mutations, nt.903G
C (P301P) and nt.987G
A (T329T), were also found
(Fig. 1D). In contrast, mutations could not be detected in
two P individuals (data not shown).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 1.
Sequencing strategy and identification of
1,4Gal-T gene mutations. A,
synthetic reaction of Gb3/Pk. B, genomic
structure of the 1,4Gal-T gene and four sets of primers
used for PCR. C, mutations found by PCR of genomic DNAs. PCR
and sequencing were performed as described under "Experimental
Procedures." The sequences of three missense mutations and one
nonsense mutation were shown. J1-J4 are of p type Japanese
individuals, and S1 and S2 are of p type Swedish individuals.
D, summary of defined mutations in the 1,4Gal-T gene.
Mutation P251L was detected in J1-J3, mutation W261stop was in J4,
mutation G187D was in S1, and mutation M183K was in S2.
|
|
Function of the Enzymes from Mutant cDNAs--
To confirm
whether the mutations G187D (S1 type), P251L (J1 type), W261stop (J4
type), and M183K (S2 type) were responsible for the defects of
1,4Gal-T activity, we examined the function of the expressed mutant
cDNAs, as well as the wild type. The expression vectors simply
containing the full-length of the coding region or myc-tagged
expression vectors for each mutant, as well as wild type, were
constructed and transfected into L cells. The M37V mutation is known
not to affect the enzyme activity (11). In the flow cytometric analysis
of L cell transfectants, the WT gene caused definite Gb3 expression. In
contrast, transfectant cells with
1,4Gal-T/J1 (J1 type) and
1,4Gal-T/S2 did not express Gb3 at all, and those with
1,4Gal-T/J4 and
1,4Gal-T/S1 expressed minimal levels of Gb3 (Fig.
2A). Myc-tagged
expression vectors and non-tagged vectors showed identical results
(data not shown). The expression levels of the transfected gene
products were almost equivalent between mutants and the wild type as
detected by an anti-myc antibody (Fig. 2B). The 42-kDa bands
seemed to be myc-tagged
1,4Gal-Ts, and a 32-kDa band seemed to be a
truncated form of
1,4Gal-T (J4) because of the stop codon at the
residue Trp261.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 2.
Cell surface expression of Gb3/Pk
antigen in L cells after transient transfection of
1,4Gal-Ts. A, Myc-tagged expression
vectors ( 1,4Gal-T/WT,
1,4Gal-T/J1,
1,4Gal-T/J4,
1,4Gal-T/S1, and
1,4Gal-T/S2, as well as
pcDNA3.1) were transfected into L cells, and
Gb3/Pk expression was tested after 48 h using anti-Gb3
monoclonal antibody 38.13 and rabbit anti-rat IgM-fluorescein
isothiocyanate (empty histgrams) or with the second antibody
alone (gray histograms). B, Western blot analysis
of myc-tagged 1,4Gal-Ts expressed in L cells. The transfected cells
were lysed, and total cell lysate (50 µg protein) was separated and
immunoblotted with mouse anti-myc-tagged antibody. Transfected plasmids
were as follows: 1, pcDNA3 and 2-6, myc
tag/pcDNA containing 1,4Gal-T/WT (lane 2);
1,4Gal-T/J1 (lane 3); 1,4Gal-T/J4 (lane 4);
1,4Gal-T/S1 (lane 5); and 1,4Gal-T/S2 (lane
6).
|
|
The
1,4Gal-T activities in the membrane fractions of the
transfectant cells were examined using lactosylceramide or
galactosylceramide as acceptors (10). All mutants exhibited loss of
enzyme activity (Fig. 3A).
Because weak Gb3 expression was detected in W261stop (J4 type) and
G187D (S1 type) by fluorescence-activated cell sorter analysis we tried
long exposure, resulting in the appearance of faint Gb3 bands in these
mutants (Fig. 3B). The enzyme activities toward
lactosylceramide were 8.46, 0.007, and 0.03 nmol/mg of protein/h for
wild type, J4, and S1, respectively (Fig. 3C). The enzyme
activities toward galactosylceramide as an acceptor were quite similar
to those for lactosylceramide (Fig. 3, D and E), i.e. two of them showed no activity, and the other two
showed minimal levels of activity only by long-exposed autofluorography (data not shown).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
1,4Gal-T activity in the
membrane from transfectant cells with 1,4Gal-T
expression vectors. A, TLC of enzyme products using
lactosylceramide (LacCer) as an acceptor. Membrane fractions
were prepared from L cells transfected with the following:
1, pcDNA3.1 and 2-6, myc tag/pcDNA
containing 1,4Gal-T/WT (lane 2); 1,4Gal-T/J1
(lane 3); 1,4Gal-T/J4 (lane 4); 1,4Gal-T/S1
(lane 5); and 1,4Gal-T/S2 (lane 6), and 50 µg of protein was used as a source of enzyme. Enzyme activity was
determined as described under "Experimental Procedures." The TLC
plate was exposed for 15 h (A) or for 5 days
(B). C, enzyme activities calculated from the
intensity of bands in A and B using
Bio-image analizer (BAS) were presented as nmol/mg/h.
D, TLC of enzyme products using galactosylceramide
(GalCer) as an acceptor. The TLC plate was exposed for
15 h. E, enzyme activities were measured from the
bands in D and a long-exposed plate (data not
shown) and were presented as nmol/mg/h.
|
|
Multiple Sequence Alignment of
1,4Gal-Ts/
1,4GlcNAc-Ts--
Based on BLAST analysis of
data bases using the coding region of
1,4Gal-T,
homologous sequences from human, other primates, rat, Drosophila
melanogaster and Arabidopsis thaliana were identified and aligned. These genes seemed to belong to the
1,4Gal-T/
1,4GlcNAc-T family. The residues
Gly187 and Pro251, which were mutated in S1 and
J1, J2, and J3 p individuals, respectively, were completely conserved
among all species examined, indicating the importance of these residues
for enzyme function. The residue Met183 was also highly conserved.
Intracellular Localization--
To investigate the mechanisms
responsible for the lack of enzyme activity in the mutant
clones, intracellular localization of the expressed enzymes was
compared. All mutants showed a similar staining pattern to the wild
type (data not shown).
 |
DISCUSSION |
In this study, we have found 3 novel mutations and one previously
reported mutation (10) in the
1,4Gal-T gene. Among 4 mutations found in the coding region, W261stop and G187D showed minimal
levels of enzyme activity, i.e. only 0.08-0.36% of the wild type. Consequently, they seemed not to be able to synthesize Gb3
in vivo, resulting in p phenotype. Our results indicated
that mutations in
1,4Gal-T had occurred at multiple and
distinct sites, at least in Japanese and Swedish individuals. The
results described here indicated that gene mutations inducing p
phenotype had been generated after the divergence of mankind into
different ethnic groups, as had mutations of the
1,2-fucosyltransferase II (Se/se) gene (12, 13). The cluster of the
gene mutation found in Vasterbotten County in Sweden may be one of the
representative mutations found in Caucasian individuals (11). This
situation is quite contrastive to the ABO blood group, in which the
polymorphism based on commonly shared gene mutations in the allelic
locus (14) is found all over the world.
The most controversial point in the P/p blood group antigen system has
been whether P1 (15) and Pk are synthesized by a single
enzyme or by distinct two enzymes (5). The ratio of
P1+/P1
is 8:2 in Caucasian individuals (1,
16) and 3:7 in Japanese individuals (17), and incidence of p is very
rare in all races, indicating that P1 synthase and Pk
synthase are not identical. Furthermore, no significant mutation in the
Gb3/CD77 synthase gene corresponding to
P1+/P1
phenotypes could be found in the
studies of our own (data not shown) and other groups (11), confirming
that the Gb3/CD77 synthase gene is not responsible for the synthesis of
P1. Actually, no incorporation of [14C]Gal onto
paragloboside could be detected in the substrate specificity analysis
of the cloned cDNA (10). The remaining mystery is that the p
phenotype is always associated with a lack of P1 expression. One
explanation is that Gb3/CD77 synthase acts exclusively toward lactosylceramide, and P1 synthase mainly utilizes neolacto-series acceptors but also, to some degree, lactosylceramide. In this case, p
phenotype can be generated only when inactivation of both of these two
enzyme genes occurs, although other reasons are possible (5).
In contrast to the
1,3-galactosyltransferase or
1,4-galactosyltransferase families (18), the
1,4Gal-T/
1,4GlcNAc-T gene family has only two members
in mammals. No other homologous cDNA was detectable in any data
base a year ago (10). Surprisingly, the same Gb3/CD77 synthase cDNA
was subsequently cloned using
1,4GlcNAc-T cDNA (19)
as a probe for PC cloning (11). Furthermore, from sequences
that have been deposited within the last year, many homologous
cDNAs to
1,4Gal-T can now be found in the data base
of many other species from primates to insects or plants (Fig.
4). These genes share several highly
homologous regions conserved through all species examined, and it is
significant that all missense mutations found in human p phenotype
occurred in these conserved regions (Fig. 4).

View larger version (88K):
[in this window]
[in a new window]
|
Fig. 4.
Alignment of
1,4Gal-T/ 1,4GlcNAc-T genes. Multiple sequence
analysis (ClustalW) of 1,4Gal-T homologues was performed. The
arrowheads indicate the mutated residues. Residues
highlighted by a black or gray
background are identical or highly conserved, respectively. Note
that Gly187 and Pro251 were completely, and
Met183 was highly, conserved among species examined.
The numbers in the parentheses indicate
GenBankTM accession numbers.
|
|
These results indicate that this gene family has been conserved because
of its importance in the survival or protection of the host against
exogenous invasions, although the real substrates for these gene
products in individual species remain to be identified. Recent studies
on the substrate preferentiality of an
1,4Gal-T in insect cells
suggest that the activity may be toward Gal
1,3GalNAc
1-R and not for Gal
1,4Glc- structures (20). Consequently, enzyme products of these sequence-conserved genes may not necessarily be
identical, and utilized nucleotide sugars may also be diverse, as shown
in the analysis of the
1,3Gal-T family (18, 21).
p individuals produce natural anti-Pk, anti-P, and anti-P1
IgG antibodies (22, 23), resulting in the high incidence of spontaneous
abortion (23). Gb3/CD77 has been considered to mediate apoptosis of B
cells (8). Furthermore, it was recently reported that Gb3/CD77 might be
involved in the fusion and entry of human immunodeficiency virus, type
I (24, 25) or in the initiation of signal transduction (26). Thus, the
presense or absence of the antigen might strongly affect the cellular
phenotype and the health of humans. Precise roles of Gb3/CD77 and its
derivatives will be investigated using the obtained cDNA and/or
targeted disruption of the
1,4Gal-T gene.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Anna Pirkola at Finnish Red
Cross Blood Transfusion Service for helpful discussions. We also thank
Dr. Kenneth O. Lloyd at Memorial Sloan-Kettring Cancer Center for
carefully reading the manuscript.
 |
FOOTNOTES |
*
This work was supported by Grants-in-Aid for the Center of
Excellence Research (10CE2006) and Scientific Research of Priority Areas (12215058, 12204055, and 10178104) from the Ministry of Education, Science, Sports and Culture of Japan and by a grant-in-aid from the Mizutani Foundation.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Dept. of Biochemistry
II, Nagoya University School of Medicine, 65 Tsurumai, Showa-ku, Nagoya
466-0065, Japan. Tel.: 81-52-744-2070; Fax: 81-52-744-2069; E-mail:
koichi@med.nagoya-u.ac.jp.
Published, JBC Papers in Press, September 18, 2000, DOI 10.1074/jbc.C000625200
 |
ABBREVIATIONS |
The abbreviations used are:
Gb3, globotriaosylceramide, (Pk, CD77,
Gal
1,4Gal
1,4Glc-ceramide);
Gb4, globotetraosylceramide, (P, GalNAc
1,3Gal
1,4Gal
1,4Glc-Cer);
1, 4Gal-T,
1,4-galactosyltransferase;
PCR, polymerase chain reaction;
nt., nucleotide;
WT, wild type;
1, 4GlcNAc-T,
1,4N-acetylglucosaminyltransferase.
 |
REFERENCES |
| 1.
|
Landsteiner, K.,
and Levine, P.
(1927)
Proc. Soc. Exp. Biol. Med.
24,
941-943
|
| 2.
|
Hilderbrand, J.,
and Hauser, G.
(1969)
J. Biol. Chem.
244,
5170-5180
|
| 3.
|
Kijimoto-Ochiai, S.,
Naiki, M.,
and Makita, A.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5407-5410
|
| 4.
|
Marcus, D.,
Naiki, M.,
and Kundu, S.
(1976)
Proc. Natl. Acad. Sci. U. S. A.
73,
3263-3267
|
| 5.
|
Naiki, M.,
and Marcus, D. M.
(1975)
Biochemistry
14,
4837-4841
|
| 6.
|
Wiels, J.,
Fellous, M.,
and Tursz, T.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
6485-6488
|
| 7.
|
Klein, G.,
Manneborg-Sandlund, A.,
Ehlin-Henriksson, B.,
Godal, T.,
Wiels, J.,
and Tursz, T.
(1983)
Int. J. Cancer
31,
535-542
|
| 8.
|
Mangeney, M.,
Richard, Y.,
Coulaud, D.,
Tursz, T.,
and Wiels, J.
(1991)
Eur. J. Immunol.
21,
1131-1140
|
| 9.
|
Karmali, M. A.
(1989)
Clin. Microbiol. Rev.
2,
15-38
|
| 10.
|
Kojima, Y.,
Fukumoto, S.,
Furukawa, K.,
Okajima, T.,
Wiels, J.,
Yokoyama, K.,
Suzuki, Y.,
Urano, T.,
Ohta, M.,
and Furukawa, K.
(2000)
J. Biol. Chem.
275,
15152-15156
|
| 11.
|
Steffensen, R.,
Carlier, K.,
Wiels, J.,
Levery, S. B.,
Stroud, M.,
Cedergren, B.,
Nilsson, S. B.,
Bennett, E. P.,
Jersild, C.,
and Clausen, H.
(2000)
J. Biol. Chem.
275,
16723-16729
|
| 12.
|
Kudo, T.,
Iwasaki, H.,
Nishihara, S.,
Shinya, N.,
Ando, T.,
Narimatsu, I.,
and Narimatsu, H.
(1996)
J. Biol. Chem.
271,
9830-9387
|
| 13.
|
Kelly, R. J.,
Rouquier, S.,
Giorgi, D.,
Lennon, G. G.,
and Lowe, J. B.
(1995)
J. Biol. Chem.
270,
4640-4649
|
| 14.
|
Yamamoto, F.,
Clausen, H.,
White, T.,
Marken, J.,
and Hakomori, S.
(1990)
Nature
345,
229-233
|
| 15.
|
Naiki, M.,
Fong, J.,
Ledeen, R.,
and Marcus, D. M.
(1975)
Biochemistry
14,
4831-4837
|
| 16.
|
Daniels, G. L.,
Anstee, D. J.,
Cartron, J. P.,
Dahr, W.,
Garratty, G.,
Henry, S.,
Jorgensen, J.,
Judd, W. J.,
Kornstad, L.,
Levene, C.,
Lomas-Francis, C.,
Lubenko, A.,
Moulds, J. J.,
Moulds, J. M.,
Moulds, M.,
Overbeeke, M.,
Reid, M. E.,
Rouger, P.,
Scott, M.,
Seidl, S.,
Sistonen, P.,
Tani, Y.,
Wendel, S.,
and Zelinski, T.
(1999)
Vox Sang.
77,
52-57
|
| 17.
|
Tomisawa, S.,
Kogure, T.,
Kuroume, T.,
Leffler, H.,
Lomberg, H.,
Shimabukoro, N.,
Terao, K.,
and Svanborg Eden, C.
(1989)
Scand. J. Infect. Dis.
21,
403-408
|
| 18.
|
Amado, M.,
Almeida, R.,
Schwientek, T.,
and Clausen, H.
(1999)
Biochim. Biophys. Acta
1473,
35-53
|
| 19.
|
Nakayama, J.,
Yeh, J. C.,
Misra, A. K.,
Ito, S.,
Katsuyama, T.,
and Fukuda, M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8991-8996
|
| 20.
|
Lopez, M.,
Gazon, M.,
Juliant, S.,
Plancke, Y.,
Leroy, Y.,
Strecker, G.,
Cartron, J. P.,
Bailly, P.,
Cerutti, M.,
Verbert, A.,
and Delannoy, P.
(1998)
J. Biol. Chem.
273,
33644-33651
|
| 21.
|
Zhou, D.,
Dinter, A.,
Gutierrez Gallego, R.,
Kamerling, J. P.,
Vliegenthart, J. F.,
Berger, E. G.,
and Hennet, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
406-411
|
| 22.
|
Soderstrom, T.,
Enskog, A.,
Samuelsson, B. E.,
and Cedergren, B.
(1985)
J. Immunol.
134,
1-3
|
| 23.
|
Yoshida, H.,
Ito, K.,
Kusakari, T.,
Ida, K.,
Ihara, Y.,
Mori, T.,
and Matsumura, M.
(1994)
Transfusion
34,
702-705
|
| 24.
|
Puri, A.,
Hug, P.,
Jernigan, K.,
Barchi, J.,
Kim, H. Y.,
Hamilton, J.,
Wiels, J.,
Murray, G. J.,
Brady, R. O.,
and Blumenthal, R.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14435-14440
|
| 25.
|
Hammache, D.,
Yahi, N.,
Maresca, M.,
Pieroni, G.,
and Fantini, J.
(1999)
J. Virol.
73,
5244-5248
|
| 26.
|
Song, Y.,
Withers, D. A.,
and Hakomori, S.
(1998)
J. Biol. Chem.
273,
2517-2525
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Iwamura, K. Furukawa, M. Uchikawa, B. N. Sojka, Y. Kojima, J. Wiels, H. Shiku, T. Urano, and K. Furukawa
The Blood Group P1 Synthase Gene Is Identical to the Gb3/CD77 Synthase Gene: A CLUE TO THE SOLUTION OF THE P1/P2/p PUZZLE
J. Biol. Chem.,
November 7, 2003;
278(45):
44429 - 44438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hellberg, J. Poole, and M. L. Olsson
Molecular Basis of the Globoside-deficient Pk Blood Group Phenotype. IDENTIFICATION OF FOUR INACTIVATING MUTATIONS IN THE UDP-N-ACETYLGALACTOSAMINE: GLOBOTRIAOSYLCERAMIDE 3-beta -N-ACETYLGALACTOSAMINYLTRANSFERASE GENE
J. Biol. Chem.,
August 9, 2002;
277(33):
29455 - 29459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. X. Zhang, J. Nakayama, E. Hidaka, S. Kubota, J. Yan, H. Ota, and M. Fukuda
Immunohistochemical Demonstration of {{alpha}}1,4-N-acetylglucosaminyltransferase that Forms GlcNAc{{alpha}}1,4Gal{beta} Residues in Human Gastrointestinal Mucosa
J. Histochem. Cytochem.,
May 1, 2001;
49(5):
587 - 596.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.